Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9850320 Heterodimeric antibodies to CD3 X CD20

Patent 9850320 was granted and assigned to Xencor on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9850320

Patent Inventor Names

Seung Chu0

Umesh Muchhal0

Gregory Moore0

John Desjarlais0

Matthew J. Bernett0

Rumana Rashid0

Sung-Hyung Lee0

Date of Patent

December 26, 2017

Patent Application Number

15185958

Date Filed

June 17, 2016

Patent Citations Received

‌

US Patent 11884720 Antibody constructs for MSLN and CD3

Patent Primary Examiner

‌

Sean Aeder

Patent abstract

The present invention is directed to novel heterodimeric antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9850320 Heterodimeric antibodies to CD3 X CD20

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API